SS
RLAY icon

SBI Securities’s Relay Therapeutics RLAY Stock Holding History

SBI Securities’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$23.5K Sell
1,258
-206
-14% -$2.99K ﹤0.01% 1488
2026
Q1 		$14.6K Buy
1,464
+11
+0.8% +$98 ﹤0.01% 1586
2025
Q4 		$12.3K Buy
1,453
+447
+44% +$3.19K ﹤0.01% 1633
2025
Q3 		$5.25K Sell
1,006
-1
-0.1% -$4 ﹤0.01% 2024
2025
Q2 		$3.48K Buy
1,007
+322
+47% +$958 ﹤0.01% 2155
2025
Q1 		$1.79K Sell
685
-7
-1% -$27 ﹤0.01% 2337
2024
Q4 		$2.85K Buy
+692
New +$3.77K ﹤0.01% 2148

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

SBI Securities's RLAY Position: Q2 2026 in Review

SBI Securities reduced its Relay Therapeutics (RLAY) stake by 14% in Q2 2026, selling an estimated $2.99K and leaving 1,258 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1488.

SBI Securities first reported a position in RLAY in Q4 2024 and has held it in 7 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • SBI Securities held 1,258 shares of Relay Therapeutics worth $23.5K as of Q2 2026.
  • SBI Securities sold 206 Relay Therapeutics shares in Q2 2026, an estimated $2.99K.
  • Relay Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1488 holding.
  • SBI Securities first reported a position in Relay Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.